Delivery Order SPE2DB22D1002-SPE2DB24FKXV8
Award Date 2/8/24
Potential Completion Date 2/9/24
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product CAPLYTA 21 MG CAPSULE 30S. The contract has a ceiling value of $1,253.37 and a performance period through April 10, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $7,046.43 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of CAPLYTA 42 MG CAPSULE 30S. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,173.63, is for the delivery of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
- Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price Delivery Order contract by the Defense Logistics Agency (DLA) to provide CAPLYTA 42 MG capsules for a potential value of $2,038.18. The contract has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on an Indefinite Delivery Contract (IDC) awarded by DLA with a potential value of up to $999,999,999.00 through December 31, 2025, which...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,004.95, is a delivery order for the drug CAPLYTA 10.5 MG CAPSULE 30S. It has an ultimate completion date of April 7, 2025. The contract is a firm fixed-price agreement and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $8,573.37 for the provision of CAPLYTA 21 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of November 15, 2023 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,472.32 firm fixed-price delivery order is for the supply of CAPLYTA 21 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award to Amerisourcebergen Drug Corp is a $6,353.03 firm-fixed-price delivery order for CAPLYTA 42 MG CAPSULE 30S, awarded by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 14, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award. The company holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,067.73, is a Delivery Order for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 14, 2025 and is a Firm Fixed Price contract. There is no set-aside designation indicated for this award....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication CAPLYTA 42 MG CAPSULE 30S. The contract, valued at $1,128.17, is a firm fixed-price delivery order with an ultimate completion date of April 16, 2024. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., has been awarded this contract without a set-aside designation, indicating it was...